Wheelchair Manufacturing in European Union 2026: Industry Statistics & Trends

The wheelchair manufacturing sector in the European Union comprises the industrial production of both manual (non-mechanically propelled) and powered (motorised) assistive mobility devices under the NACE classification system. The industry is shifting progressively toward technologically advanced powered solutions, lightweight composite materials, and custom-molded seating systems to meet the complex medical needs of an aging European demographic. To illustrate the sector's scale, Germany, which represents the largest domestic market in the Union, recorded an estimated electric wheelchair market size of USD 1.12 billion in 2025 (industry sources/Eurostat-derived population statistics), while

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Wheelchair Manufacturing in European Union industry cover?

The wheelchair manufacturing industry in the European Union is officially classified under the manufacture of transport equipment, specifically encompassing products designed for individuals with physical disabilities. The scope spans non-motorised manual wheelchairs, powered or motorised wheelchairs, mobility scooters, and specialized replacement parts or accessories. It explicitly excludes retail-only distribution, general medical furniture, or non-mobility orthopaedic appliances.

• •Classified under NACE Rev. 2 Code 30.92, which covers the 'Manufacture of bicycles and invalid carriages'.
• •Divided at the PRODCOM product level into non-mechanically propelled invalid carriages (PRODCOM 30.92.20.30) and motorised or mechanically propelled invalid carriages (PRODCOM 30.92.20.90).
• •Includes specialized parts and accessories under PRODCOM 30.92.30, covering dedicated frames, custom seating, and control systems.

Who operates in the industry and how is it structured?

The European Union wheelchair manufacturing sector operates as a moderately concentrated market characterized by a mix of specialized regional manufacturers and major multinational corporations with European assembly or production bases. Production is highly concentrated in Western and Northern Europe, with Germany, Sweden, and Belgium acting as key manufacturing hubs. These operators heavily rely on public healthcare tenders, insurance reimbursement systems, and direct institutional procurement.

• •Major EU-based manufacturing facilities are operated by regional specialists including Vermeiren Group in Belgium, Etac AB in Sweden, and Meyra GmbH in Germany.
• •A substantial share of production is tied to public tenders from state healthcare agencies, such as the German Gesetzliche Krankenversicherung (GKV) and the French Assurance Maladie.
• •Smaller, highly specialized SMEs focus on bespoke, high-end manual sports and active-user wheelchairs to differentiate from mass-market imports.

What drives demand in the industry?

The primary catalyst for industry demand is the rapidly aging demographic profile of the European Union, which correlates with an increasing prevalence of mobility impairments and chronic diseases. Institutional shift towards homecare settings and independent living models further accelerates the procurement of both standard and foldable mobility units. Additionally, national healthcare reimbursement policies act as the financial foundation for market volume.

• •The proportion of the EU population aged 65 or older is projected by Eurostat to rise continuously, driving long-term structural demand for personal mobility devices.
• •Homecare settings are expanding rapidly across the EU, increasing the demand for highly maneuverable, lightweight, and foldable designs.
• •Government initiatives, such as Spain’s Recovery and Resilience Plan, have directly funded accessibility and clinical rehabilitation equipment upgrades in recent years.

Who are the notable companies in the industry?

Competition within the EU wheelchair manufacturing space is defined by intense product innovation, particularly in smart-drive systems, battery technologies, and ergonomic structures. Market participants must balance highly specialized, low-volume custom medical builds with automated, high-volume production of standard hospital transport chairs. The landscape features several prominent European entities alongside international giants with dedicated European subsidiaries.

• •Vermeiren NV (Vermeiren Group), headquartered in Belgium, operates major production lines producing manual and electric wheelchairs.
• •Etac AB, a Sweden-based developer of assistive devices, actively manufactures adaptable manual wheelchairs, pediatric mobility aids, and custom seating.
• •Eloflex AB, a subsidiary of the Swedish publicly listed industrial trading group Teqnion AB, specializes in innovative foldable electric wheelchairs.
• •Sunrise Medical (US/Global) and Permobil AB (Sweden) maintain extensive manufacturing, customization, and engineering facilities across multiple EU member states.

What are the recent trends and outlook?

The industry is experiencing a rapid technological transition from traditional sealed lead-acid batteries toward lithium-ion systems, which offer significantly longer range and lower overall vehicle weight. There is also a distinct regulatory and corporate emphasis on circular economy models, including remanufacturing and component recycling. Manufacturers are investing in 3D-printing technologies to produce personalized cushions and structural elements optimized for specific individual postures.

• •Lithium-ion battery adoption is expanding at an estimated 10% annual rate, outstripping legacy sealed lead-acid options due to weight and performance advantages.
• •Corporate life-cycle assessments (LCA) conducted by European firms demonstrate that remanufactured frames can reduce carbon emissions by up to 50% compared to brand-new units.
• •The adoption of center-wheel drive electric configurations is rising as clinicians prioritize tight turning radii suitable for modern, urban European housing retrofits.

How is the industry regulated?

Wheelchairs manufactured or distributed within the European Union are legally classified as Class I medical devices and must meet stringent European safety, performance, and environmental standards to achieve CE marking. Compliance demands have intensified with the transition to the Medical Device Regulation (MDR), which imposes stricter clinical evaluation and post-market surveillance. Additionally, battery-powered units must comply with rigorous updated environmental rules concerning product life cycle and material recovery.

• •Must comply strictly with Regulation (EU) 2017/745 (Medical Device Regulation / MDR), requiring robust clinical data and unique device identification (UDI) tracking.
• •Battery-powered electric models are subject to the stringent compliance parameters of EU Battery Regulation 2023/1542, impacting sourcing, carbon footprint declaration, and end-of-life recycling.
• •Safety and structural requirements must conform to harmonised ISO standards, notably EN 12183 for manual wheelchairs and EN 12184 for electrically powered wheelchairs and scooters.

Government, statistical and trade sources used for this Claight analysis.

• Eurostat NACE Rev. 2 Classification Database 2025 ·
• Commission Implementing Regulation (EU) 2026/665 establishing the industrial products classification ·
• Federal Statistical Office of Germany (Destatis) 2025 ·
• Official Journal of the European Union - Medical Device Regulation (EU) 2017/745